IL-31 Blockade The IL-31Ra antagonist nemolizumab had a highly significant antipruritic effect in patients with moderate to severe AD ( 64 ).
1
—
—
IL-31 Blockade The IL-31Ra antagonist nemolizumab had a highly significant antipruritic effect in patients with moderate to severe AD ( 64 ).